Line 282: |
Line 282: |
| | | | | |
| |- | | |- |
| + | |Low grade gliomas, WHO grade I-II |
| + | |- |
| + | | |
| + | |Pilocytic astrocytoma |
| + | |'''Gain:''' 5, 7, 6, 11<br> |
| + | '''Loss:''' 1, 2, 3, 13, 14, 16, 17, 19 |
| + | |'''Fusion:''' KIAA1549-BRAF fusion (via 3'BRAF duplication), other BRAF partners reported; NTRK fusions (rare)<br> |
| + | '''Mutation:''' FGFR1 |
| + | |Aneuploidy is more predominant in adult PA; Infratentorial tumors are more likely to have BRAF fusions/dup and be wildtype for BRAF mutations; Extra-cerebellar tumors are more likely to be BRAF V600E+, but negative for fusion; Surgical resection can be curative |
| + | |PMID: 24470550; PMID:26378811; PMID: 25664944; PMID:26992069 |
| + | |- |
| + | | |
| + | |Pleomorphic xanthoastrocytoma (PXA) |
| + | |'''Gain:''' 7, 2, 5, 21, 20, 12, 15<br> |
| + | '''Loss:''' monosomy 9 / 9p deletion most common, 22, 14, 13, 10<br> |
| + | '''CN-LOH:''' 9p, 22 |
| + | |'''Loss:''' homozygous loss CDKN2A/B<br> |
| + | Mutation: BRAF V600E |
| + | |Adults and pediatric tumors show similar CNVs; CDKN2A/CDKN2B loss may correlate with anaplastic histology |
| + | |PMID:23442159; PMID:28181325 |